These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC method. Yang H; Parniak MA; Hillier SL; Rohan LC J Incl Phenom Macrocycl Chem; 2012 Apr; 72(3-4):459-465. PubMed ID: 26097403 [TBL] [Abstract][Full Text] [Related]
4. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. Aleem O; Kuchekar B; Pore Y; Late S J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363 [TBL] [Abstract][Full Text] [Related]
5. Inclusion complexation of pinostrobin with various cyclodextrin derivatives. Kicuntod J; Khuntawee W; Wolschann P; Pongsawasdi P; Chavasiri W; Kungwan N; Rungrotmongkol T J Mol Graph Model; 2016 Jan; 63():91-8. PubMed ID: 26709752 [TBL] [Abstract][Full Text] [Related]
6. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies. Aloisio C; Longhi M Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845 [TBL] [Abstract][Full Text] [Related]
7. Spectral and theoretical study on complexation of sulfamethoxazole with β- and HPβ-cyclodextrins in binary and ternary systems. Varghese B; Suliman FO; Al-Hajri A; Al Bishri NSS; Al-Rwashda N Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():392-401. PubMed ID: 28950231 [TBL] [Abstract][Full Text] [Related]
8. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes. Giastas P; Yannakopoulou K; Mavridis IM Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820 [TBL] [Abstract][Full Text] [Related]
9. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials. Phan CM; Subbaraman LN; Jones L J Biomater Sci Polym Ed; 2014; 25(17):1907-19. PubMed ID: 25226305 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Liu L; Zhu S J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859 [TBL] [Abstract][Full Text] [Related]
11. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350 [TBL] [Abstract][Full Text] [Related]
12. Evaluating solubility, stability, and inclusion complexation of oxyresveratrol with various β-cyclodextrin derivatives using advanced computational techniques and experimental validation. Ali S; Aman A; Hengphasatporn K; Oopkaew L; Todee B; Fujiki R; Harada R; Shigeta Y; Krusong K; Choowongkomon K; Chavasiri W; Wolschann P; Mahalapbutr P; Rungrotmongkol T Comput Biol Chem; 2024 Oct; 112():108111. PubMed ID: 38879954 [TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin. Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438 [TBL] [Abstract][Full Text] [Related]
14. Non-inclusion complexes between riboflavin and cyclodextrins. de Jesus MB; Fraceto LF; Martini MF; Pickholz M; Ferreira CV; de Paula E J Pharm Pharmacol; 2012 Jun; 64(6):832-42. PubMed ID: 22571261 [TBL] [Abstract][Full Text] [Related]
15. A molecular dynamics study of conformations of beta-cyclodextrin and its eight derivatives in four different solvents. Khuntawee W; Karttunen M; Wong-Ekkabut J Phys Chem Chem Phys; 2017 Sep; 19(35):24219-24229. PubMed ID: 28848954 [TBL] [Abstract][Full Text] [Related]
16. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Aloisio C; Gomes de Oliveira A; Longhi M Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444 [TBL] [Abstract][Full Text] [Related]
17. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249 [TBL] [Abstract][Full Text] [Related]
18. Experimental and Computational Investigation of Clustering Behavior of Cyclodextrin-Perfluorocarbon Inclusion Complexes as Effective Histotripsy Agents. Kaymaz B; Mustafa W; Hall S; Vlaisavljevich E; Sensoy O; Yuksel Durmaz Y Mol Pharm; 2022 Aug; 19(8):2907-2921. PubMed ID: 35839291 [TBL] [Abstract][Full Text] [Related]
19. Inclusion Complexation of Organic Micropollutants with β-Cyclodextrin. Erdős M; Hartkamp R; Vlugt TJH; Moultos OA J Phys Chem B; 2020 Feb; 124(7):1218-1228. PubMed ID: 31976678 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives. Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]